Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: A prospective study

Influenza and other Respiratory Viruses

Volumn 5, Issue 1, 2011, Pages 7-11

  McVernon, Jodie ^a   Laurie, Karen ^b   Barr, Ian ^b   Kelso, Anne ^b   Skeljo, Maryanne ^a   Nolan, Terry ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b World Health Organisation Collaborating Centre for Reference Research on Influenza   (Australia)

Author keywords

Australia; H1N1 subtype; Human; Influenza; Influenza A virus; Influenza vaccines; Paediatrics; Pandemic

Indexed keywords

CROSS REACTING ANTIBODY; INFLUENZA VACCINE;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNOGENICITY; INFANT; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; PANDEMIC INFLUENZA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SEASONAL INFLUENZA; SEROCONVERSION; VACCINATION; VIRUS STRAIN;

ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CROSS REACTIONS; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PANDEMICS; PROSPECTIVE STUDIES; SEASONS; VACCINATION;

EID: 78650083170     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2010.00172.x     Document Type: Article

References (20)

1. Sullivan SJ, Jacobson RM, Dowdle WR, Poland GA. 2009 H1N1 influenza. Mayo Clin Proc 2010; 85(1):64-76.
2. Human infection with new influenza A (H1N1) virus: clinical observations from Mexico and other affected countries. Wkly Epidemiol Rec 2009; 84(21):185-196.
3. Fraser C, Donnelly CA, Cauchemez S et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science 2009; 324(5934):1557-1561.
4. Nishiura H, Castillo-Chavez C, Safan M, Chowell G. Transmission potential of the new influenza A(H1N1) virus and its age-specificity in Japan. Euro Surveill 2009; 14(22):19227.
5. McBryde E, Bergeri I, Van Gemert C et al. Early transmission characteristics of influenza A(H1N1)v virus in Australia: Victorian state. Euro Surveill 2009; 14(42):19363.
6. Bansal S, Pourbohloul B, Hupert N, Grenfell B, Meyers LA. The shifting demographic landscape of pandemic influenza. PLoS ONE 2010; 5(2):e9360.
7. Cauchemez S, Donnelly CA, Reed C et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med 2009; 361(27):2619-2627.
8. Katz J, Hancock K, Veguilla V et al. Serum Cross-Reactive Antibody Response to a Novel Influenza A (H1N1) Virus After Vaccination with Seasonal Influenza Vaccine. MMWR Morb Mortal Wkly Rep 2009; 58(19):521-524.
9. Hancock K, Veguilla V, Lu X et al. Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus. N Engl J Med 2009; 361(20):1945-1952.
10. Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE Jr, Wilson IA. Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus. Science 2010; 328(5976):357-360.
11. Medlock J, Galvani AP. Optimizing Influenza Vaccine Distribution. Science 2009; 325(5948):1705-1708.
12. National Health and Medical Research Council (Australia) & Nolan, Terry & Immunise Australia Program & Australia. Dept. of Health and Ageing. Australian Technical Advisory Group on Immunisation 2008, The Australian immunisation handbook NHMRC. The Australian Immunisation Handbook, 9th edn. Canberra: Australian Government Department of Health and Ageing, 2008.
13. Concepts and Procedures for Laboratory-based influenza surveillance. WHO Collaborating Centres for Reference and Research on Influenza. 1982 (September).
14. Tannock GA, Paul JA, Herd R et al. Improved colorimetric assay for detecting influenza B virus neutralizing antibody responses to vaccination and infection. J Clin Microbiol 1989; 27(3):524-528.
15. Nolan T, McVernon J, Skeljo M et al. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. JAMA 2010; 303(1):37-46.
16. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010; 375(9720):1100-1108.
17. Ikonen N, Strengell M, Kinnunen L et al. High frequency of cross-reacting antibodies against 2009 pandemic influenza A (H1N1) virus among the elderly in Finland. Euro Surveill 2010; 15(5):19478.
18. Kobinger GP, Meunier I, Patel A et al. Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus. J Infect Dis 2010; 201(7):1000-1006.
19. Del Giudice G, Stittelaar KJ, Van Amerongen G et al. Seasonal influenza vaccine provides priming for A/H1N1 immunization. Sci Transl Med. 2009; 1(12):12re1.
20. Laurie K, Carolan L, Middleton D, Lowther S, Kelso A, Barr I. Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model. J Infect Dis 2010; in press.